Literature DB >> 15538739

Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.

Christiane Jakob1, Daniela E Aust, Wolfdietrich Meyer, Gustavo B Baretton, Wolfgang Schwabe, Peter Häusler, Heinz Becker, Torsten Liersch.   

Abstract

Pre-operative 5-fluorouracil (5-FU)-based chemoradiotherapy in locally advanced rectal cancer (UICC-II/III) may significantly reduce local tumour mass. Response to pre-operative treatment, however, varies significantly. Thymidylate synthase (TS), thymidine phosphorylase (TP), and dihydropyrimidine dehydrogenase (DPD) are thought to be important predictors for the efficiency of 5-FU-based treatment. The aim of this study was to determine the correlation between TS-, TP-, and DPD-gene expression and the response to 5-FU-based long-term pre-operative chemoradiotherapy assessed by histopathological tumour regression. Additionally, the predictive value of intra-tumoural TS-, TP-, and DPD-gene expression in pre-operative rectal tumour biopsies was assessed by correlation with the histopathological regression grade. Formalin-fixed, paraffin wax-embedded pre-operative biopsies (n = 14) and surgical resection specimens (n = 40) from patients with rectal carcinoma (clinical UICC stage II/III) receiving neo-adjuvant 5-FU-based chemoradiotherapy were studied for TS-, TP-, and DPD-gene expression by quantitative TaqMan real-time PCR after laser microdissection. Results were compared with standardized histopathological tumour regression analysis. There was a significant association between low TS-gene expression in pre-operative tumour biopsies and tumour response (p = 0.02). TS- and TP-gene expression was significantly lower in resection specimens of responders than of non-responders (p = 0.02) when microdissection was used. Statistical significance was even higher when TS and TP were combined (p = 0.0001). For the DPD gene, no significance was found at all. In conclusion, this study shows that TS gene expression in a pretreatment biopsy predicts the response of local rectal cancer to neo-adjuvant 5-FU-based chemoradiotherapy in a high percentage. Moreover, intra-tumoural TS- and TP-gene expression in surgical rectal specimens after neo-adjuvant chemoradiotherapy correlates significantly with histopathological tumour regression when microdissection is applied. Copyright (c) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538739     DOI: 10.1002/path.1663

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

1.  [Response prediction--early response evaluation. Consequences for surgical oncology].

Authors:  J R Siewert; F Lordick
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

Review 2.  [Individualizing treatment for locally advanced rectal cancer].

Authors:  T Liersch; H Rothe; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

Review 3.  Molecular Biology: Are We Getting Any Closer to Providing Clinically Useful Information?

Authors:  Georgios Karagkounis; Matthew F Kalady
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 4.  Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update.

Authors:  Pan Xie; Jun-Luan Mo; Jin-Hong Liu; Xi Li; Li-Ming Tan; Wei Zhang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Cell Oncol (Dordr)       Date:  2020-05-30       Impact factor: 6.730

5.  Adjuvant therapy for rectal cancer.

Authors:  Smitha S Krishnamurthi; Yuji Seo; Timothy J Kinsella
Journal:  Clin Colon Rectal Surg       Date:  2007-08

6.  Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapy.

Authors:  Marian Grade; Jochen Gaedcke; Danny Wangsa; Sudhir Varma; Jaje Beckmann; Torsten Liersch; Clemens Hess; Heinz Becker; Michael J Difilippantonio; Thomas Ried; B Michael Ghadimi
Journal:  Cancer Genet Cytogenet       Date:  2009-08

7.  Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.

Authors:  Christiane Jakob; Torsten Liersch; Wolfdietrich Meyer; Heinz Becker; Gustavo-B Baretton; Daniela-E Aust
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

8.  Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Enrico Benzoni; Giovanni Terrosu; Donatella Intersimone; Elisa Milan; Germana Chiaulon; Vittorio Bresadola; Cosimo Sacco; Elisa Sattin; Fabrizio Bresadola; Claudio Avellini
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

9.  Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer.

Authors:  E Benzoni; D Intersimone; G Terrosu; V Bresadola; A Cojutti; F Cerato; C Avellini
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

10.  Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatment.

Authors:  Lena-Christin Conradi; Annalen Bleckmann; Markus Schirmer; Thilo Sprenger; Peter Jo; Kia Homayounfar; Hendrik A Wolff; Hilka Rothe; Peter Middel; Heinz Becker; Michael B Ghadimi; Tim Beissbarth; Torsten Liersch
Journal:  Ann Surg Oncol       Date:  2011-02-23       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.